Illumina Q1 Revenues Grow 6 Percent, Miss Estimates | GenomeWeb

NEW YORK (GenomeWeb) – Illumina reported after the close of the market on Tuesday that it missed its first quarter 2016 revenue forecast, consistent with a preliminary estimate it provided last month.

Illumina's Q1 revenues were up 6 percent to $571.8 million from $538.6 million in the prior-year quarter. Analysts, on average, had predicted the firm would recognize $596.3 million. On a constant currency basis, revenues were up 7 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.

Sponsored by

This webinar will discuss a project that sought to understand the parent-of-origin epigenetic mechanisms that regulate seed development in plants, with a particular emphasis on differentiating the maternal or paternal origin of epigenetics marks.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.